dilluns, 29 de setembre del 2014

Appeals court vacates FDA's rescission of ReGen's MenaFlex implant




A federal appeals court vacates the FDA's decision to rescind its 510(k) clearance for ReGen Biologics' MenaFlex knee implant, ordering the watchdog agency to conduct "further proceedings."








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://www.massdevice.com/news/appeals-court-vacates-fdas-rescission-regens-menaflex-implant

Cap comentari:

Publica un comentari a l'entrada